Holen Sie sich die Stockscreener-App
1.11
11.20%
-0.14
Finanzdaten der Alzamend Neuro Inc-Aktie (ALZN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
8.33%
2.6599
|
2.9017 | 3.5259 | - | - |
| Interest Income/Expense |
42.29%
0.00249
|
0.00431 | 0.00184 | 0.000519 | 0.00206 |
| Operating Income/Loss |
8.33%
-2.6599
|
-2.9017 | -3.5259 | -3.305 | -5.4235 |
| Nonoperating Income/Loss |
42.29%
-0.00249
|
-0.00431 | -0.00184 | -0.000519 | -0.00206 |
| Income/Loss From Continuing Operations Before Tax |
192.91%
2.70
|
-2.906 | 3.50 | -26.48 | 5.40 |
| Income/Loss From Continuing Operations After Tax |
192.91%
2.70
|
-2.906 | 3.50 | -26.48 | 5.40 |
|
Net Income/Loss
|
192.91%
2.70
|
-2.906 | 3.50 | 3.30 | 5.40 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
5.3624
|
- | 7.0278 | 6.6055 | 10.83 |
| Basic Average Shares |
7.47%
7.0543
|
6.5638 | 98.44 | - | - |
| Diluted Average Shares |
7.47%
7.0543
|
6.5638 | 98.44 | -0.2465 | 98.33 |
| Basic Earnings Per Share |
13.64%
-0.38
|
-0.44 | -0.04 | -0.03 | -0.06 |
| Diluted Earnings Per Share |
13.64%
-0.38
|
-0.44 | -0.04 | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):